Business & Finance
Alvotech and Lotus agree licensing deal for two biosimilar candidates
21 August 2026 - Global biotechnology company Alvotech SA (NASDAQ: ALVO; STO: ALVO-SDB), which develops and manufactures biosimilar medicines, said on Friday it has signed a strategic licensing and co...
Quest Diagnostics declares quarterly dividend of of USD0.86 per share
13 August 2026 - Quest Diagnostics (NYSE:DGX), a provider of diagnostic information services, announced on Wednesday that its board of directors declared a quarterly cash dividend of USD0.86 per share...
BSF secures exclusive global commercialisation partnership for ETSYL
11 August 2026 - BSF Enterprise plc (LON:BSFA), a biotechnology company focused on tissue engineering, lab-grown materials and bioactive solutions, said on Tuesday that it has signed Heads of Terms wi...
Saniona grants AstronauTx worldwide rights to neurological disease programme
10 August 2026 - Clinical-stage biopharmaceutical company Saniona AB (STO:SANION) announced on Monday that biotechnology company AstronauTx Ltd has exercised its option to acquire exclusive worldwide ...
Ridgetech reports financial results for fiscal year to March 2026
3 August 2026 - Ridgetech Inc (Nasdaq:RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, on Friday reported its financial results for the fiscal year ended 31 Mar...
AMGEN announces Q3 2026 dividend
31 July 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Thursday that its board of directors has declared a dividend of USD2.52 per share for the third quarter of 2026.This amount...